First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA.
Int J Clin Oncol
; 27(4): 695-706, 2022 Apr.
Article
in En
| MEDLINE
| ID: mdl-35182247
Full text:
1
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
Type of study:
Clinical_trials
Limits:
Adolescent
/
Humans
Language:
En
Year:
2022
Type:
Article